Fantastic outline E! Wish you were on the BOD! lol

First 144 Last

Share
Profile

Follow
MrFantastic

2,835 Posts.

1247

11/07/20

21:14

Post #: 45802171
Share

Originally posted by Exalted: ↑

On stocks that run like ESK/ATH tape reading is probably the most valuable skill to have...

Charting takes a backseat on the day of the mega pump itself. One minute chart would help and being able to tape read.

Anyways, that's all speculation and IHL probably wont get that kind of treatment unless the market gods will it so.

In the short term we have lots to look forward to!

Next week should come Stage 1 ARDS results, would be huge for the credibility of the BOD and IHL.
The BOD should also provide us guidance on when Stage 2 of the ARDS trial will commence.

On or before July 31st, Q2 Quarterly should come out. I'd be eyeing the costs of that one. I also suspect due to the amount of oppie conversions including Sud's $480K conversion could result in IHL having a positive quarter. I will also be looking at the other quarterlies of our peers, in particular AGH. Guidance for Q3 sales (right now) should also be in the quarterly and as per the Ann of Record Sales momentum is expected to continue into Q3.

By August 5 Ethics for OSA Phase 2B should be fully submitted to the Alfred Ethics Committee and that should pass quickly.
Commencement of the OSA Trial should probably happen shortly after! We know that IHL has sourced the patients already as per previous announcements... And as per ANZCTR its 30 patients, and should last 5 weeks. That could be updated and we will need new guidance to see.

It's also possible we see TBI Animal Trials to be commenced this quarter as well. Unfortunately the human trials for that will likely be on hold as long as the MMA has been affected by COVID.

Not to mention the possibilities of a Company Preso, New Website, Roadshow etc. Excited!

Expand

Fantastic outline E! Wish you were on the BOD! lol

IHL Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

1 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve made uranium history – redefining what it means to be “high grade”

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV